Vivera Pharmaceuticals, a pharmaceutical company located in Southern California, announced on Tuesday that it has added Saurabh Radhakrishnan to the company's Advisory Board.
In the new role, Radhakrishnan is to support Vivera in its development and commercialisation initiatives for ZICOH, the firm's high-tech, electronic, dose-controlled medication delivery system, aimed at improving prescription drug adherence.
The company says that Radhakrishnan serves as an executive and serial entrepreneur with a passion for technology. He has diverse experience in the medical device industry with hands-on involvement in various stages of the product life cycle, which includes research and development, manufacturing, regulatory, and commercialisation strategy.
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project